[Early diagnosis, prevention and treatment for calcific uremic arteriolopathy]

Area of Science:

• Nephrology
• Dermatology
• Pathology

Background:

• Calcific uremic arteriopathy (CUA), also known as calciphylaxis, is a rare and often fatal condition.
• CUA is characterized by medium and small arterial calcification and microthrombosis.
• Currently, there are no definitive laboratory diagnostic criteria for CUA.

Purpose of the Study:

• To highlight the importance of early diagnosis and effective treatment for CUA.
• To discuss diagnostic methods and therapeutic strategies for CUA.
• To emphasize the need for multidisciplinary management in CUA patients.

Main Methods:

• Diagnosis relies on identifying arterial calcification and microthrombosis through skin biopsy, imaging (radiologic, bone scan).
• Evidence of activated bone morphogenetic protein (BMP) signal transduction pathways aids in early diagnosis.
• Therapeutic approaches include intravenous sodium thiosulfate (STS), bisphosphonates, hyperbaric oxygen, and supportive care for wounds, pain, and nutrition.

Main Results:

• Skin biopsy, imaging, and BMP pathway activation are key indicators for early CUA diagnosis.
• Standard therapies focus on symptom management and supportive care.
• Preventive measures involve controlling chronic kidney disease-mineral and bone disorder (CKD-MBD) and dialysis/drug complications.

Conclusions:

• Despite treatments, CUA patients face a poor prognosis and high mortality.
• Rapid disease progression underscores the critical need for prompt diagnosis and intervention.
• Multidisciplinary management is essential for improving outcomes in CUA patients.